Steroid-responsive pulmonary hypertension in a patient with Langerhans' cell granulomatosis (histiocytosis X)

Chest

Volumn 110, Issue 1, 1996, Pages 284-286

  Benyounes, Bruno ^a   Crestani, Bruno ^a   Couvelard, Anne ^a   Vissuzaine, Christiane ^a   Aubier, Michel ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

Langerhans' cell granulomatosis; pulmonary hypertension; steroids

Indexed keywords

CORTICOSTEROID; PREDNISONE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CORTICOSTEROID THERAPY; HISTIOCYTOSIS X; HUMAN; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

EID: 0029971022     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.110.1.284     Document Type: Article

References (6)

1. Schwarz MI. Primary and unclassified interstitial lung diseases. In: Schwarz MI, King TE, eds. Interstitial lung disease. St. Louis: Mosby-Year Book, 1993; 413-43
2. Friedrnan PJ, Liebow AA, Sokoloff J. Eosinophilic granuloma of lung: clinical aspects of primary histiocytosis X in the adult. Medicine 1981; 60:385-96
3. Villar TG, Avila R, Amaral Marques R. Eosinophilic granuloma of the lung and the extrinsic pulmonary granulomatoses. Ann N Y Acad Sci 1976; 278:612-17
4. Virshup M, Goldman A. Eosinophilic granuloma of the lung. J Thorac Surg 1956; 31:226-37
5. Voelkel NF, Tuder R. Interleukin-1 receptor antagonist inhibits pilmonary hypertension induced by inflammation. Ann N Y Acad Sci 1994; 725:104-09
6. Rodman DM, Lindenfeld JA. Successful treatment of sarcoidosis-associated pulmonary hypertension with corticosteroids. Chest 1990; 97:500-02